SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Koolaide who wrote (112)11/5/1997 11:25:00 PM
From: Jim Mac  Read Replies (1) of 413
 
Maybe it's kinda ahead of itself, and needs to wait for earnings to appear and "catch up" with the price. That's why I posted a while back that if I owned LVCI at the time, I'd either sell and buy on a dip, or hold and add on weakness. I'm still holding, and got some more near $7 recently.

Earnings are only a Q or two away...

The one thing I'm concerned about is the potential for PRK/LASIK to become commodity services down the road, and for managed care to force the price down eventually. That would squeeze LVCI's margins. Also, I wonder what effect the small holmiums (Sunrise) and smaller excimers (Visx?) on the drawing boards will have on LVCI's business plan. The holmiums, at least, may be approved within a couple of years, and may make hyperopia treatments on excimers undesirable for most patients.

If lasers become small enough and cheap enough, LVCI's reason for being may vanish. But I'm more concerned about potential price competition down the road.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext